Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Cancer Prev ; 23(3): 911-917, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-35345363

ABSTRACT

OBJECTIVE: Breast cancer is one of the most frequently diagnosed malignancy among women. Turmeric is isolated from Curcuma longa. Curcumin is main curcuminoid of the turmeric which is a member of Zingiberaceae. In this current study antiproliferative effects of curcumin were investigated in luminal A breast cancer cell line MCF-7 and triple negative breast cancer cell line MDA-MB-231. METHODS: For this purpose cell viability, cell index values by xCELLigence Real-Time Cell Analysis DP instrument, mitotic index and apoptotic index analysis were used. RESULTS: Cell viability and cell index values showed that 75 µM concentration of curcumin was IC50 concentration. When IC50 concentration was applied to both cell lines, a significant decrease was observed in the mitotic index values, while a significant increase was observed in the apoptotic index values (p<0.05). CONCLUSION: Curcumin, which has antiproliferative effects on breast cancer cells, is thought to be effective in cancer treatment.


Subject(s)
Curcumin , Triple Negative Breast Neoplasms , Cell Survival , Curcumin/pharmacology , Female , Humans , Mitotic Index , Triple Negative Breast Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...